Search Results 81-90 of 16260 for monoclonal antibody
Dostarlimab-gxly is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...
... monoclonal antibody, and compare them with clinical outcomes. Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors. Jacksonville, Fla ...
Eculizumab-aagh injection is a monoclonal antibody that works on the immune system. This medicine is available only under a restricted distribution program ...
Interrupting the Progression of COVID-19 by Anti-Spike Monoclonal Antibodies: Outcomes in Two Eras ... Eligibility for anti-spike monoclonal antibody therapy ...
This treatment is a monoclonal antibody that decreases annual relapse rates and demonstrates MRI benefits. This medicine helps reduce relapses of MS by ...
... monoclonal antibody therapy in solid organ transplant recipients. J Med Virol. 2023 Jun; 95 (6):e28885. View PubMed; Luther VP, Barsoumian AE, Konold VJL ...
... monoclonal antibody that targets CD38, a protein found on the surface of myeloma cells, significantly reduces the risk of progression to active multiple ...
Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as rituximab, can block ...
It is a monoclonal antibody. Tocilizumab injection is also used alone or together with glucocorticoids (steroid medicine) to treat giant cell arteritis ...
Bevacizumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.